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Genotypic and Phenotypic Traits That Distinguish Neonatal Meningitis-
Associated Escherichia coli from Fecal E. coli Isolates of Healthy Human
Hosts
Abstract
Neonatal meningitis Escherichia coli (NMEC) is one of the top causes of neonatal meningitis worldwide.
Here, 85 NMEC and 204 fecal E. coli isolates from healthy humans (HFEC) were compared for possession of
traits related to virulence, antimicrobial resistance, and plasmid content. This comparison was done to identify
traits that typify NMEC and distinguish it from commensal strains to refine the definition of the NMEC
subpathotype, identify traits that might contribute to NMEC pathogenesis, and facilitate choices of NMEC
strains for future study. A large number of E. coli strains from both groups were untypeable, with the most
common serogroups occurring among NMEC being O18, followed by O83, O7, O12, and O1. NMEC strains
were more likely than HFEC strains to be assigned to the B2 phylogenetic group. Few NMEC or HFEC
strains were resistant to antimicrobials. Genes that best discriminated between NMEC and HFEC strains and
that were present in more than 50% of NMEC isolates were mainly from extraintestinal pathogenic E. coli
genomic and plasmid pathogenicity islands. Several of these defining traits had not previously been associated
with NMEC pathogenesis, are of unknown function, and are plasmid located. Several genes that had been
previously associated with NMEC virulence did not dominate among the NMEC isolates. These data suggest
that there is much about NMEC virulence that is unknown and that there are pitfalls to studying single
NMEC isolates to represent the entire subpathotype.
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Genotypic and Phenotypic Traits That Distinguish Neonatal
Meningitis-Associated Escherichia coli from Fecal E. coli Isolates of
Healthy Human Hosts
Catherine M. Logue,a,b Curt Doetkott,c Paul Mangiamele,a Yvonne M. Wannemuehler,a Timothy J. Johnson,a,d Kelly A. Tivendale,a,e
Ganwu Li,a Julie S. Sherwood,b and Lisa K. Nolana
Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, Iowa State University, Ames, Iowa, USAa; Department of Veterinary and
Microbiological Sciences, North Dakota State University, Fargo, North Dakota, USAb; Information Technology Services, North Dakota State University, Fargo, North Dakota,
USAc; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, USAd; and Faculty of Veterinary Science, The University of
Melbourne, Parkville, Victoria, Australiae
Neonatal meningitis Escherichia coli (NMEC) is one of the top causes of neonatal meningitis worldwide. Here, 85 NMEC and 204
fecal E. coli isolates from healthy humans (HFEC) were compared for possession of traits related to virulence, antimicrobial re-
sistance, and plasmid content. This comparison was done to identify traits that typify NMEC and distinguish it from commensal
strains to refine the definition of the NMEC subpathotype, identify traits that might contribute to NMEC pathogenesis, and facil-
itate choices of NMEC strains for future study. A large number of E. coli strains from both groups were untypeable, with the
most common serogroups occurring among NMEC being O18, followed by O83, O7, O12, and O1. NMEC strains were more
likely than HFEC strains to be assigned to the B2 phylogenetic group. Few NMEC or HFEC strains were resistant to antimicrobi-
als. Genes that best discriminated between NMEC and HFEC strains and that were present in more than 50% of NMEC isolates
were mainly from extraintestinal pathogenic E. coli genomic and plasmid pathogenicity islands. Several of these defining traits
had not previously been associated with NMEC pathogenesis, are of unknown function, and are plasmid located. Several genes
that had been previously associated with NMEC virulence did not dominate among the NMEC isolates. These data suggest that
there is much about NMEC virulence that is unknown and that there are pitfalls to studying single NMEC isolates to represent
the entire subpathotype.
Despite advances in antimicrobial therapy, Gram-negativeneonatal bacterialmeningitis continues to be amajor cause of
mortality and morbidity worldwide, with neonatal meningitis
Escherichia coli (NMEC) being one of the top two causes of neo-
natal bacterial meningitis in industrialized countries, along with
group B streptococci (22, 23, 26). Most of the survivors of Gram-
negative neonatal bacterial meningitis suffer neurologic sequelae
or developmental abnormalities (23), and if left untreated, this
disease is usually fatal. Better control of NMEC diseases is desir-
able in order to alleviate human suffering and to decrease the
financial burden caused by bacterial meningitis.
Unfortunately, current knowledge of NMEC pathogenesis is
incomplete, complicating efforts to control or eliminate this dis-
ease. In the review of E. coli pathogenicity by Croxen and Finlay
(5), deficits in our understanding of NMEC pathogenesis become
apparent. For instance, it is clear that many NMEC strains lack
cnf1, a factor thought to be critical in NMEC pathogenesis (19). In
addition, we have shown that NMEC strains tend to harbor genes
found among plasmid-located pathogenicity islands (PAIs) in
avian pathogenic E. coli (APEC) (19). Such plasmids are fre-
quently transferable by conjugation (9, 12, 13, 17, 31) and have
been shown to confer on their host E. coli the abilities to survive in
the bloodstream, traverse the blood-brain barrier of mammals,
and cause bacteremia and meningitis in the rat model of human
disease (13, 32). In some cases, such virulence plasmids also har-
bor resistance genes conferring multidrug resistance on their host
bacterium (13). Despite the fact that it has been long known that
plasmids occur in NMEC (26, 29, 32) and are linked to E. coli
virulence (16), their contributions to NMEC pathogenesis are ill
defined and understudied. Thus, there appears to be some deficits,
perhaps important ones, in our knowledge of NMEC pathogene-
sis. Here, we seek to lay the groundwork for addressing these
knowledge gaps by determining what traits distinguish NMEC
from human fecal commensal E. coli.
MATERIALS AND METHODS
Bacterial strains. A total of 289 E. coli isolates were used in this study,
including 85 from cases of human neonatal meningitis (NMEC) and 204
from the feces of healthy human hosts (HFEC). Seventy of the NMEC
isolates came from the cerebrospinal fluid of newborns in The Neth-
erlands and were isolated between 1989 and 1997 (11) (courtesy of L.
Spanjaard). The remaining NMEC isolates were isolated over the same
time period from patients in the United States and were provided by K. S.
Kim and C. DebRoy. The HFEC strains were obtained from two sources:
179 were provided to us by J. Johnson, and the remainder was isolated for
this study as follows. Human fecal samples were collected from healthy
human volunteers at North Dakota State University using internal review
board (IRB)-approved protocols. Swabs were collected from the rectum
of healthy volunteers and transferred to Cary Blair transport medium. On
receipt at the lab, the swabs were transferred to 5 ml of buffered peptone
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water (Difco, BD Diagnostics, NJ) and incubated at 37°C for 18 to 24 h.
Following incubation, a loopful of the enrichment broth was streaked out
on MacConkey agar (MAC; Difco) and eosin methylene blue agar (EMB;
Difco) plates and incubated at 37°C for 18 to 24 h. Suspect colonies on
MAC (bright pinkwith a dimple) andEMB (green colonieswith ametallic
sheen) were selected to tryptone soy agar (TSA; Difco) for purification,
and plates were incubated at 37°C for 18 to 24 h. Identificationwas carried
out using the Sensititre GNID panels (Trek Diagnostics, Cleveland, OH),
with incubation of the panels at 37°C for 18 h. All organisms were stored
at80°C in brain heart infusion broth (Difco Laboratories, Detroit, MI)
with 20% (vol/vol) glycerol until use (28). All NMEC strains were pro-
vided to us with the serogrouping already completed, whereas all HFEC
strains were serogrouped through the Escherichia coli Reference Center
(Pennsylvania State University, University Park, PA).
Hemolytic reaction. Test and control organisms were plated on 5%
sheep blood agar plates (BD Diagnostics) and incubated overnight at 37°C.
The plates were then examined for “greening” or clearing of the blood agar
around areas of bacterial growth as an indication of hemolytic activity (8).
Fermentation of lactose.Test and control organisms were plated on
MacConkey agar (Difco) and incubated overnight at 37°C. Isolates
were considered positive for lactose utilization if pink colonies were
observed (8).
Phylogenetic typing. Isolates were assigned to phylogenetic groups ac-
cording to the PCR amplificationmethod described by Clermont et al. (4).
Multiplex PCR genotyping and plasmid replicon typing. Test and
control organisms were examined for the presence of a number of ExPEC
virulence genes, including different allelic variants, genes associated with
the pathogenicity islands (PAIs) of large ExPEC plasmids, plasmid repli-
cons, and genes of unknown function found in genomic islands of an
ExPEC isolate known as APECO1 (14) using a number of multiplex PCR
assays (see Table S1 in the supplemental material). Some of these multi-
plex panels have been previously described (12, 17, 18, 20, 27). All primers
were obtained from Integrated DNA Technologies (Coralville, IA). In all,
multiplex panels targeting 182 gene products were used, making this
study the most extensive comparative genotypic analysis of NMEC and
HFEC populations to date. PCR was performed as previously described
(27). Strains known to possess or lack the genes of interest were examined
with each amplification procedure. Reactions were performed twice. An
isolate was considered to contain a gene of interest if it produced an
amplicon of the expected size.
Antimicrobial susceptibility profiles. All isolates were subjected to
antimicrobial susceptibility testing using the broth microdilution assay
and the National Antimicrobial Resistance Monitoring Scheme
(NARMS) panels (CMV1AGNF, Sensititre; Trek Diagnostics, Cleveland,
OH), as described previously (15). Procedures, control strains (including
Escherichia coli ATCC 25922, Enterococcus faecalis ATCC 29212, and
Staphylococcus aureus ATCC 29213) and interpretative criteria were as
specified by the Clinical and Laboratory Standards Institute (CLSI) and
NARMS (1). The NARMS panel tests antimicrobial susceptibility to the
following antimicrobials: amikacin (0.5 to 64 g/ml), ampicillin (1 to 32
g/ml), amoxicillin-clavulanic acid (1/0.5 to 32/16 g/ml), ceftriaxone
(0.25 to 64g/ml), chloramphenicol (2 to 32g/ml), ciprofloxacin (0.015
to 4 g/ml), trimethoprim-sulfamethoxazole (0.12/2.38 to 4/76 g/ml),
cefoxitin (0.5 to 32 g/ml), gentamicin (0.25 to 16 g/ml), kanamycin (8
to 64 g/ml), nalidixic acid (0.5 to 32 g/ml), sulfisoxazole (15 to 256
g/ml), streptomycin (32 to 64 g/ml), tetracycline (4 to 32 g/ml), and
ceftiofur (0.12 to 8 g/ml). Resistance or susceptibility of the strain to an
antimicrobial was determined according to the observedMIC and break-
points recommended by CLSI and NARMS (1).
Breakpoints used in this study were amikacin,64g/ml; ampicillin,
32 g/ml; amoxicillin-clavulanic acid, 32/16 g/ml; ceftriaxone, 4
g/ml; chloramphenicol, 32 g/ml; ciprofloxacin, 4 g/ml; tri-
methoprim-sulfamethoxazole,4/76 g/ml; cefoxitin,32 g/ml; gen-
tamicin,16 g/ml; kanamycin,64 g/ml; nalidixic acid,32 g/ml;
sulfisoxazole, 512 g/ml; streptomycin, 64 g/ml; tetracycline, 16
g/ml; and ceftiofur,8 g/ml.
Biostatistics. A chi-square test of homogeneity was used for compar-
ison between groups, and Fisher’s exact test was used where the assump-
tions of the chi-square test did not hold (30). In a further attempt to
discern patterns among all isolates based on their content of virulence
genes, a linear discriminant analysis (LDA) was used to determine if an
isolate type (NMEC or HFEC) could be predicted based on the virulence
genes present (10). Although the use of data from binary variables in an
LDA, as done here, violates the assumption of multivariate normality,
LDA was used since parametric LDA can be very robust in spite of such
violations (24). Additionally, a cluster analysis of the isolates was per-
formed using the average linkage method based upon Jaccard’s dissimi-
larity coefficient calculated from the presence of virulence genes (SAS
9.22) (2). In order to better discern patterns among the isolates, results of
the cluster and discriminant analyses and the isolates’ virulence genotypes
and phylogenetic groups were used to construct a single figure based on
the principles of Eisen et al. (6) (Fig. 1).
RESULTS
Serogroups. Of the 85 NMEC isolates, only 65.9% (56 isolates)
could be classified to a single O serogroup using standard antisera,
while 77.5%of theHFEC isolates classified to a singleO serogroup
(Table 1). A large number of NMEC and HFEC isolates could not
be serogrouped because they were rough, autoagglutinated,
grouped to multiple serogroups, or untypeable. Among the
NMEC isolates that were serogrouped, 18 serogroups were repre-
sented, with seven of these being unique to NMEC. Among the
HFEC isolates, 54 different serogroups were found, with 43 of
these unique to HFEC. Around 54% (46) of the typeable NMEC
isolates and 30.9% (63) of the typeable HFEC isolates shared se-
rogroups. The most common serogroups found among the
NMEC isolates were O18, followed by O83, O7, O12, and O1;
among theHFEC, themost commonly occurring serogroupswere
O6, followed by O2, O25, O1, O75, O18, O8, O4, and O15.
Lactose utilization and hemolytic activity.NMEC andHFEC
isolates did not differ significantly (P  0.43) in their abilities to
hemolyze blood, with a large majority of both being nonhemo-
lytic. Although over 90% of both NMEC and HFEC isolates fer-
mented lactose, significantly (P 0.01)moreNMEC isolates than
HFEC isolates were nonfermenters.
Phylogenetic typingofNMECandHFEC isolates.NMECand
HFEC isolates differed significantly in their assignments to phylo-
genetic groups (P 0.0002), despite the fact that the majority of
both (79% of NMEC and 54% of HFEC isolates) were assigned to
group B2 (Table 2).
Genotypes and plasmid replicon content. Based on a cluster
analysis of their genotypes, NMEC and HFEC isolates were as-
signed to 11 statistically distinct clusters (Fig. 1), with one ormore
NMEC strain assigned to each cluster. The majority of NMEC
isolates were assigned to cluster 4, a cluster whose members were
characterized by their possession of genes of plasmid PAIs, un-
known function, the yersiniabactin operon, known PAIs, and pu-
tative PAIs.
Linear discriminant analysis of genotyping data found that 21
of 289 isolate assignments weremispredictions. That is, 18NMEC
isolates were incorrectly predicted to be HFEC, while three HFEC
isolates were inaccurately predicted to be NMEC.
Virulence gene/trait count analysis of the isolates examined in
the study found that the numbers of genes/traits were greatest
among the NMEC isolates (pink group; 80 to 100 genes pos-
NMEC Traits
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sessed), while the HFEC isolates were likely to possess consider-
ably fewer of the genes/traits (green and yellow groups; 40 to 60
genes possessed).
Several genes were identified in the genotype analysis that oc-
curred in the majority of NMEC isolates (50%) but were found
infrequently inHFEC isolates (Table 3 and Fig. 1; see also Table S2
in the supplemental material), making them good discriminators
of NMEC from HFEC. Identified genes included those associated
with ExPECplasmid PAIs, i.e., ompTp, hlyF, cvaC, etsA, cvaA, etsB,
cvaB, iss, iutA, and tsh (Table 3). Also, certain genes of unknown
function found in the genomic islands of ExPEC strain APEC O1
(i.e., 2093, 2095, 2102, and 2103), aec35 (an lacI family transcrip-
tional regulator of APEC strain BEN2908’s PAI), and certain
known chromosomal virulence genes (i.e., sfaS, cdtB, and papGI)
were also found to be good discriminators, though not all oc-
curred in over half of the NMEC isolates studied (Table 3). In
addition, NMEC isolates were more likely to harbor the FIB rep-
licon, a replicon type that typifies ExPEC virulence plasmids but is
also common in many wild-type E. coli isolates (16, 20).
It was especially interesting that NMEC andHFECwere signif-
icantly different in their possession of genes from APEC genomic
islands. In fact, other than the plasmid PAI genes, several of these
genomic island genes were among the best discriminators of
NMEC and HFEC. For instance, gene target aec35 occurred in
75% of NMEC isolates but only in 2% of HFEC isolates. This
differencewas very highly significant (2 179.3282,P 0.0001),
suggesting that this gene or the island in which it is containedmay
be involved in NMEC pathogenesis or fitness.
Several genes known for their contributions to NMEC patho-
genesis were not as widespread among NMEC isolates as other
traits implicated in pathogenesis, including cnf1, which occurred
in less than 5% of NMEC isolates; ibeA and gimB, which occurred
in 60% of NMEC isolates; and sfa-foc, which occurred in only
55.3% of NMEC isolates. Several other traits occurred in signifi-
cantly more NMEC than HFEC isolates but did not occur in the
majority of NMEC isolates tested (bmaE, papGI=, cdtB, B/O, and P
replicon types and certain genomic island genes of unknown func-
tion) (see Table S2 in the supplemental material and Table 3). In
addition, some genes that occurred in a high number of NMEC
isolates showed a significant associationwithNMECbut were also
found in amajority ofHFEC isolates, rendering them less useful in
accurately predictingNMECorHFEC status but still typical of the
NMEC subpathotype (e.g., sitA, traT, eaeH, fyuA, irp2, kpsMTII,
malX PAI, vat, FIB replicon type, and other genes of unknown
function) (Table 3).
Antimicrobial susceptibility profiles. NMEC and HFEC iso-
lates were also compared by their susceptibility to several antimi-
crobial agents (Table 4). Almost one-third of the NMEC isolates
were resistant to streptomycin and sulfisoxazole, while about one-
fifth were resistant to ampicillin, 15% were resistant to tetracy-
cline, and a few were resistant to chloramphenicol, kanamycin,
and trimethoprim-sulfamethoxazole. Antimicrobial resistance
was also observed in some of the HFEC isolates examined, with
resistance to tetracycline (13.7%), sulfisoxazole (12.3%), and tri-
methoprim-sulfamethoxazole (7.4%) being the most common.
DISCUSSION
If the E. coli strains causing meningitis in human neonates use a
common set of virulence factors to do so, theywould constitute an
ExPEC subpathotype (21). In an effort to identify common traits
that unite theNMEC subpathotype, 85E. coli isolates fromcases of
human neonatal bacterial meningitis were compared to 204 iso-
lates from the feces of healthy human hosts for possession of var-
ious traits, including those associated with ExPEC virulence, re-
sistance, and genomic and plasmid islands. As it turns out, typical
NMEC isolates ferment lactose but do not hemolyze blood. This
pattern is also true of HFEC, meaning that lactose fermentation
and hemolytic ability cannot be used to discriminate HFEC and
NMEC. Although NMEC and HFEC strains differ significantly in
their distributions among the phylogenetic groups, their patterns
of distribution are similar to the majority of NMEC and HFEC
strains being assigned to the B2 phylogenetic group. Thus, while
assignment to the B2 phylogenetic group is typical of NMEC, phy-
logenetic grouping also fails to distinguish NMEC from HFEC.
This finding is interesting since ExPEC strains are thought to be-
long predominately to group B2 and to a lesser extent to group D
(4), suggesting that several of the HFEC isolates studied here
might harbor pathogenic potential or that the association between
phylogenetic group and pathogenicity is not distinct in the case of
HFEC. For further discussion of this issue, see the work of Bailey
et al. (3).
Although there were a few NMEC isolates that belonged to
serogroups not found among the HFEC isolates tested, none of
these serogroups were common. Indeed, the more common sero-
groups occurring in NMEC, such as O18, O83, and O7, were also
found in HFEC. Antimicrobial susceptibility patterns also failed
to provide a clear distinction between NMEC and HFEC, despite
the fact that most of the NMEC isolates were harvested from in-
fants in Europe from the late 1980s through the 1990s (11), while
the HFEC isolates were harvested from people in North America
more recently.
A greater percentage of NMEC isolates than HFEC isolates
FIG 1 Gel diagrammerging the cluster analysis and LDA of the genotyping results of NMEC and HFEC strains. The first row (the uppermost row at the top of
the figure) identifies the clusters to which the isolates were assigned based on their genotypes. There are 11 identified clusters: 1, magenta; 2, gray; 3, navy blue;
4, yellow; 5, orange; 6, lime green; 7, salmon; 8, brick red; 9, black; 10, bright pink; and 11, cyan. The second row shows the accuracy of prediction from the linear
discriminant analysis (LDA) of an isolate type based on possession of genes/traits. Green indicates a correct prediction as to whether an isolate is an NMEC or an
HFEC strain, whereas red indicates a misprediction, with 21 instances observed. The third row indicates the source of the isolates, where HFEC strains are
denoted as green, and NMEC strains are identified in yellow. The next set of rows of red and black bars (rows 4 through 185; not numbered) shows the results
for a single gene or trait. The identity of each gene tested is shown in the column at the far right of the diagram (below cluster, accuracy, and source). In the body
of the figure, a black line means that the gene of interest is present in a particular isolate, whereas a red line means the gene is absent. The row following the black
and red pattern (row 186) shows the source of the isolates (same as the third row from the top). Row 187 (made up of brown, green, blue, and orange colors)
indicates the phylogenetic groups of each isolate: blue, phylogenetic group A; orange, B1; brown, B2; and green, D. Row 188 (the last row of the figure) indicates
the gene/trait content for each strain, where isolates in category 1 contain 1 to 20 of the tested genes/traits and are identified as dark lime; category 2 isolates are
identified in light lime and possess 20 to 40 genes; category 3 isolates are identified in yellow and possess 40 to 60 genes; category 4 isolates are identified in orange
and possess 60 to 80 genes; and category 5 isolates are identified in bright pink and possess 80 to 100 genes. This figure is also available online at http://ecoli.cvm
.iastate.edu:81/blast/images/Figure1nmec.jpg.
NMEC Traits
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showed resistance to the antimicrobials streptomycin, sulfisoxa-
zole, and tetracycline, with the biggest differential occurring for
streptomycin and sulfisoxazole; but still, these differences were
not dramatic, and neither group had 31% ormore of its members
resistant to any antimicrobial tested. Also, about a fifth of the
NMEC isolates were predicted to be HFEC based on their posses-
sion of the assessed traits, while less than 2%ofHFEC isolateswere
predicted to be NMEC. Such a high percentage of mispredictions
of NMEC as HFEC complicates making a clear definition of the
NMEC subpathotype, but it also presents hypotheses for future
testing, i.e., that the mispredicted NMEC isolates are opportunis-
tic pathogens, whereas the correctly assigned NMEC isolates are
frank pathogens or that NMEC harbor as-of-yet-unknown viru-
lence traits lacking in HFEC that enable NMEC’s pathogenic life-
style.
There were some distinct differences in the occurrence of dif-
ferent plasmid replicons in NMEC and HFEC isolates, with Inc
types B/O, P, and FIB significantly more likely (P 0.01) to occur
in NMEC than in HFEC isolates. However, Inc P replicons oc-
curred in few strains overall, and Inc B/O replicons occurred in
less than 50% of NMEC isolates and15% of HFEC isolates. The
difference in distribution of the Inc FIB replicon is intriguing since
it occurs in over 90% of NMEC isolates and in only 55% of HFEC
isolates, a difference that is very highly significant. It is also inter-
esting from a biological standpoint since it is this replicon type
that is typical of large ExPEC virulence plasmids, which harbor
PAIs (16). The validity of this observation was also reinforced by
the findings that most of the plasmid PAI genes assessed in this
study were significantly more likely to occur in NMEC than in
HFEC isolates and occurred in most of the NMEC and few HFEC
TABLE 1 Serogroups among NMEC and HFEC isolates
Serogroup
No. (%) of isolates
NMEC (n 85) HFEC (n 204)
Shared
O1 4 9
O4 1 5
O6 2 21
O7 6 1
O12 4 1
O16 1 3
O18 17 7
O21 2 2
O25 1 11
O78 1 1
O83 7 2
Subtotal 46 63
% total shared (54.1) (30.9)
Unshared
O2 0 21
O8 0 6
O9 1 0
O11 0 3
O14 2 0
O15 0 4
O19 0 3
O23 2 0
O29 0 1
O37 0 2
O38 0 1
O44 0 1
O45 2 0
O46 0 1
O48 0 1
O54 0 2
O55 0 1
O68 0 1
O73 0 3
O74 0 2
O75 0 8
O77 0 1
O81 0 1
O84 1 0
O86 0 3
O88 0 1
O90 0 1
O97 0 1
O101 0 2
O102 0 1
O104 0 1
O105 0 1
O106 0 2
O109 0 1
O113 0 3
O117 0 2
O118 0 1
O120 0 2
O131 0 1
O135 1 0
O138 0 1
O147 0 1
O148 0 1
O153 0 1
O154 0 1
TABLE 1 (Continued)
Serogroup
No. (%) of isolates
NMEC (n 85) HFEC (n 204)
O156 0 1
O166 1 0
O167 0 1
O168 0 1
O171 0 1
Subtotal 10 95
% total unshared (11.8) (46.6)
Total no. (%) typed 56 (65.9) 158 (77.5)
None (not serogrouped)
Nontypeable 29 45
Multiple serogroups 0 1
Subtotal 29 46
% total untyped (34.1) (22.5)
TABLE 2 Assignment of isolates to phylogenetic groupsa
Isolate
No. (%) of isolates by group
Total no. of
isolatesA B1 B2 D
NMEC 9 (10.6) 1 (1.2) 67 (78.8) 8 (9.4) 85
HFEC 33 (16.2) 32 (15.7) 110 (53.9) 29 (14.2) 204
Total 42 33 174 37 289
a Chi-square test for homogeneous assignment to phylogenetic group: 2 19.51, df
3, P 0.0002.
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isolates, making them among the most discriminatory traits stud-
ied here. Thus, it would appear that virulence plasmids typify the
NMEC subpathotype.
This finding is significant in that the role of virulence plasmids
in the pathogenesis of E. coli-caused neonatal meningitis has been
given only limited scrutiny, with much of what we know of them
found in literature published over 3 decades ago (29) or based on
APEC plasmids and their contributions to meningitis (13). These
findings may have important implications for the future study of
NMEC pathogenesis, since at least two of the most frequently
studied NMEC strains, whose genomes have been completely se-
quenced (NMEC IHE3034 and RS218) (25), lack these plasmid
PAIs. Thus, it would appear that in order to gain a more complete
and/or accurate understanding of NMEC pathogenesis, it will be
necessary to include plasmid PAI-containing strains in future
studies.
Indeed, until it is routinely possible to perform full genome-
wide functional analyses of multiple NMEC strains simultane-
ously, in-depth analysis of a few NMEC strains, selected for their
NMEC typicality, might be a useful strategy to maximize the gen-
eralizability of the results obtained. Based on the findings of this
study, a typical NMEC strain would belong to the B2 phylogenetic
group and O18:K1:H7 serotype; be nonhemolytic; ferment lac-
tose; contain a large PAI-containing plasmid, likely of the Inc FIB
replicon type; and lack cnf1 and hlyD, while harboring vat and
ibeA genes, part of the pap, sfa, auf, and yersiniabactin operons,
and certain genes of previously unknown genomic islands. For
such a strain to prove a useful reagent in future studies of NMEC
pathogenesis, it would also need to cause bacteremia and menin-
gitis in the rat model of human neonatal meningitis and traverse
cultured human brain microvascular endothelial cells. Cases
could also be made for using other strains to represent the NMEC
subpathotype based on these data, but regardless of which strain
or strains we use to represent this group, recognition that there are
limitations on the generalizability of data generated from their
study is in order.
In addition to guiding the selection of NMEC for future study,
identification of traits that occur commonly amongNMEC strains
and that discriminate them fromHFEC strains may have value in
tracking NMEC strains back to their point of origin, enabling new
interventions to prevent transmission of NMEC to neonates. It
might also provide useful targets that could be exploited in vaccine
design. Thus, determining what traits define the NMEC sub-
pathotype and distinguish them from human commensals would
seem to be a useful effort. Assuming this is so, a community effort
to collate and expand ourNMEC andHFEC collections and assess
them for distinguishing traits is highly desirable.
Finally, the results of this study reinforce previous findings (7,
14, 19, 32) that NMEC and APEC subpathotypes share significant
similarities. For instance, both contain plasmid PAIs as a domi-
nant and defining trait, and severalNMEC strains contain genes of
ill-defined function that were originally identified in the genomic
islands of APEC O1, the only APEC strain whose full genomic
sequence is publicly available (14). Whether these similarities in-
dicate that NMEC and APEC share a lineage or harbor zoonotic
potential is not clear, but future comparative studies of represen-
tative NMEC and APEC strains will be useful in deciphering the
significance of these observed similarities.
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TABLE 3 The 20 traits with the greatest differential in percent positives
between NMEC and HFEC isolates
Gene/traita
No. (%) of isolates containing trait
Chi-square
value PNMEC (n 85) HFEC (n 204)
aec35 64 (75.3) 4(2) 179.33 0.0001
ompTp 57 (67.1) 8 (3.9) 137.20 0.0001
hlyF 53 (62.4) 8(3.9) 123.02 0.0001
cvaC 49 (57.6) 8 (3.9) 109.38 0.0001
etsA 54 (63.5) 14 (6.9) 107.08 0.0001
cvaA 61 (71.8) 29 (14.2) 92.67 0.0001
etsB 52 (61.2) 17 (8.3) 92.18 0.0001
cvaB5= 58 (68.2) 27 (13.2) 87.42 0.0001
iss 48 (56.5) 15 (7.4) 84.91 0.0001
sfaS 42 (49.4) 14 (6.9) 69.53 0.0001
iutA 68 (80) 55 (27) 69.04 0.0001
2093 55 (64.7) 33 (16.2) 66.72 0.0001
2101 55 (64.7) 33 (16.2) 66.72 0.0001
cdtB 32 (37.7) 5 (2.5) 66.58 0.0001
tsh 28 (32.9) 2 (0.9) 65.88 0.0001
2103 55 (64.7) 34 (16.7) 64.71 0.0001
2095 55 (64.7) 34 (16.7) 64.701 0.0001
cvaB3= 55 (64.7) 35 (17.2) 64.71 0.0001
2078 33 (38.8) 7 (3.4) 63.02 0.0001
papG1* 48 (56.5) 28 (13.7) 56.56 0.0001
a The traits are listed in descending order based on the magnitude of the chi-square
value, with the most powerful trait being aec35, which contributes to the virulence of
APEC BEN2908. The next 8 traits have been found among the PAIs of large APEC
virulence plasmids. The tenth trait listed, sfaS, occurs in just under half of the NMEC
isolates examined. The next two traits, 2093 and 2101, were originally found in a
genomic island of APEC O1 and have not previously been ascribed a function or
associated with ExPEC virulence. The remaining traits had smaller differences in
prevalence rates and thus lower chi-square values, either because they occurred
relatively more frequently in HFEC isolates or relatively less frequently in NMEC
isolates than the more discriminating traits. Interestingly, many of the better-studied
NMEC virulence traits, such as gimB, ibeA, or cnf1, did not make this list, suggesting
that there is much yet unknown about NMEC pathogenesis.
TABLE 4 Antimicrobial susceptibility profiles of NMEC and HFEC
Antimicrobial agent
No (%) of isolates resistant
NMEC HFEC
Amikacin 0 (0) 0 (0)
Amoxicillin-clavulanic acid 3 (3.5) 4 (2)
Ampicillin 20 (23.5) 37 (18.2)
Cefoxitin 0 (0) 3 (1.5)
Ceftiofur 0 (0) 0 (0)
Ceftriaxone 0 (0) 0 (0)
Chloramphenicol 2 (2.4) 6 (3)
Ciprofloxacin 0 (0) 1 (0.5)
Gentamicin 0 (0) 2 (1)
Kanamycin 2 (2.4) 0 (0)
Nalidixic acid 0 (0) 1 (0.5)
Streptomycin 26 (30.6) 13 (6.4)
Sulfisoxazole 25 (29.4) 25 (12.3)
Tetracycline 13 (15.3) 28 (13.7)
Trimethoprim-sulfamethoxazole 6 (7.1) 15 (7.4)
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